Author | Todd Bauer, MD | OncLive

Author | Todd Bauer, MD

Articles

Dr. Bauer on Evolution of Phase I Trials

March 20, 2017

Video

Todd Bauer, MD, associate director, Drug Development, principal investigator, Sarah Cannon Research Institute, discusses how phase I clinical trial programs are evolving and becoming more beneficial for patients with cancer.

Dr. Bauer on Rovalpituzumab Tesirine in SCLC

October 04, 2016

Video

Todd Bauer, MD, associate director, Drug Development, Sarah Cannon Research Institute, discusses the emergence of the novel agent rovalpituzumab tesirine in the treatment of patients with small cell lung cancer in an interview during the IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology.

Dr. Bauer on Rovalpituzumab Tesirine in Patients With SCLC

July 05, 2016

Video

Todd Bauer, MD, associate director, Drug Development, principal investigator, Sarah Cannon Research Institute, discusses the safety and efficacy of single-agent rovalpituzumab tesirine (Rova-T), a delta-like protein 3 (DLL3)-targeted antibody-drug conjugate in recurrent/refractory patients with small cell lung cancer (SCLC).

x